Skip to content
AwardedIRLServices€120,000

CDMO Services for Development and Validation of a Colorectal Cancer Screening Immunoassay

Published
Published 17 April 2026
Deadline
Closed 7 May 2026

Overview

Trinity College Dublin appointed Fleet Bioprocessing as a Contract Development and Manufacturing Organisation (CDMO) to provide assay optimization, clinical and analytical validation protocols, control documentation design, and manufacturing development services for a colorectal cancer screening immunoassay. The contract, valued at EUR 115,000, was awarded on 18 May 2026.

Key details

Country
IRL
Status
Awarded
Category
Services
Estimated value
€120,000
Procedure
Open
Published
17 April 2026
Deadline
Closed
Classification (CPV)
Research and experimental development services

Award outcome

Awarded value
€115,000
Award date
18 May 2026
Contract period
— → 9 November 2027
Winner
  • Fleet Bioprocessing

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    10 June 2026

  2. Contract Notice

    17 April 2026

Contracting authority

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: CDMO Services for Development and Validation of a Colorectal Cancer Screening Immunoassay — won by Fleet Bioprocessing — Skim